Welcome to our dedicated page for Streamline Health Solutions In SEC filings (Ticker: STRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Streamline Health Solutions, Inc. (STRM) SEC filings page on Stock Titan provides access to the company’s historical regulatory documents, including key filings associated with its merger and change in listing status. Streamline Health is a healthcare technology company that enables healthcare organizations to proactively address revenue leakage and improve financial performance through integrated solutions, technology-enabled services and analytics.
For investors and researchers, Streamline Health’s annual reports on Form 10-K and quarterly reports on Form 10-Q have included discussions of its SaaS-based revenue cycle solutions, financial results prepared in accordance with U.S. GAAP, and non-GAAP metrics such as Adjusted EBITDA and Booked SaaS Annual Contract Value (ACV). These filings also contain detailed risk factor and management’s discussion and analysis (MD&A) sections that the company cites in its press releases.
More recent filings document the company’s transition from a Nasdaq-listed issuer to a privately held subsidiary of Mist Holding Co., the parent of MDaudit. An 8-K filed on August 13, 2025 describes the completion of the merger in which a subsidiary of Mist Holding Co. merged with and into Streamline Health, with Streamline Health surviving as a wholly owned subsidiary. A Form 25 filed on August 12, 2025 reports the removal of Streamline Health’s common stock from listing on the Nasdaq Stock Market, and a Form 15 filed on August 22, 2025 certifies the termination of registration of the company’s common stock and the suspension of its reporting obligations under Sections 13 and 15(d) of the Securities Exchange Act of 1934.
On Stock Titan, users can review these and other historical SEC filings for STRM with AI-powered summaries that highlight key terms, structural changes, and financial disclosures. The platform is designed to help readers quickly understand complex documents, from merger-related 8-Ks and proxy materials to periodic reports, while also surfacing information related to capital structure changes and reporting status.
Streamline Health Solutions, Inc. submitted a Form 25 notifying removal of its common stock from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer's principal office and telephone number, cites Nasdaq's statement that it complied with applicable rules to file Form 25, and is signed by Jennifer Fainer, CDO Analyst, dated 2025-08-12.
Streamline Health Solutions, Inc. (Nasdaq: STRM) has mailed a Definitive Proxy Statement (DEFM14A) asking shareholders to approve its all-cash acquisition by Mist Holding Co./MDaudit for $5.34 per share. The Special Meeting will be held virtually on 7 August 2025. If completed, Merger Sub will merge into Streamline, turning the company into a wholly-owned subsidiary of MDaudit, after which STRM shares will be delisted and deregistered.
Financial terms: Holders receive $5.34 in cash for each share—representing a 138% premium to the 28 May 2025 close and a 117% premium to the 30-day VWAP. All restricted shares and in-the-money options/warrants convert to cash on the same economic basis; out-of-the-money options and warrants are cancelled for no consideration. The buyer has certified it possesses sufficient cash, and the deal is not subject to a financing condition.
Approvals & key hurdles: • Merger Proposal requires an unusually high two-thirds (66 ⅔ %) of outstanding STRM shares. • Compensation and Adjournment Proposals require a simple majority of votes cast. • 21.82% of shares are already locked up via Voting Agreements with officers/directors. • Outside closing date is 31 Dec 2025; parties target 3Q-2025 completion. • Standard closing conditions apply, including no injunctions and accuracy of reps & warranties.
Governance & deal protections: • Streamline has a customary “no-shop” clause with fiduciary-out and five-business-day match right. • A termination fee of $950,000 (≈2.3% of equity value) is payable under specified circumstances, including a superior proposal. • Appraisal rights are available to shareholders who strictly follow DGCL §262 procedures.
Strategic rationale highlighted by the Board: Cain Brothers opined that the consideration is fair from a financial perspective. Directors cite immediate liquidity at a substantial premium, certainty of value, and lack of financing risk. The Board unanimously recommends voting “FOR” all three proposals.
Implications for investors: Shareholders gain immediate cash at a triple-digit premium but forgo future upside and lose public equity liquidity. Failure to achieve the two-thirds threshold or satisfy closing conditions would leave STRM independent, potentially causing the share price to revert toward pre-announcement levels. Active voting is critical because non-votes count as “AGAINST” the Merger Proposal.